BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22152226)

  • 1. Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system.
    Remouchamps C; Boutaffala L; Ganeff C; Dejardin E
    Cytokine Growth Factor Rev; 2011; 22(5-6):301-10. PubMed ID: 22152226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
    Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
    Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor.
    Etemadi N; Holien JK; Chau D; Dewson G; Murphy JM; Alexander WS; Parker MW; Silke J; Nachbur U
    FEBS J; 2013 Nov; 280(21):5283-97. PubMed ID: 23815148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease.
    Browning JL
    Immunol Rev; 2008 Jun; 223():202-20. PubMed ID: 18613838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
    Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
    Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
    Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
    Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.
    Madge LA; Kluger MS; Orange JS; May MJ
    J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
    J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury.
    Ruddell RG; Knight B; Tirnitz-Parker JE; Akhurst B; Summerville L; Subramaniam VN; Olynyk JK; Ramm GA
    Hepatology; 2009 Jan; 49(1):227-39. PubMed ID: 19111021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.
    Jungbeck M; Stopfer P; Bataille F; Nedospasov SA; Männel DN; Hehlgans T
    Mol Immunol; 2008 Jan; 45(1):34-41. PubMed ID: 17590442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transcriptional regulation of TNF/LT locus in immune cells].
    Shebzukhov IuV; Kuprash DV
    Mol Biol (Mosk); 2011; 45(1):56-67. PubMed ID: 21485497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor.
    Ganeff C; Remouchamps C; Boutaffala L; Benezech C; Galopin G; Vandepaer S; Bouillenne F; Ormenese S; Chariot A; Schneider P; Caamaño J; Piette J; Dejardin E
    Mol Cell Biol; 2011 Nov; 31(21):4319-34. PubMed ID: 21896778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
    Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
    J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R; Cuff CA; Lesslauer W; Ruddle NH
    J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo.
    Abe K; Yarovinsky FO; Murakami T; Shakhov AN; Tumanov AV; Ito D; Drutskaya LN; Pfeffer K; Kuprash DV; Komschlies KL; Nedospasov SA
    Blood; 2003 Feb; 101(4):1477-83. PubMed ID: 12560241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
    Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
    Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development.
    Wolf MJ; Seleznik GM; Zeller N; Heikenwalder M
    Oncogene; 2010 Sep; 29(36):5006-18. PubMed ID: 20603617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.
    Seleznik G; Seeger H; Bauer J; Fu K; Czerkowicz J; Papandile A; Poreci U; Rabah D; Ranger A; Cohen CD; Lindenmeyer M; Chen J; Edenhofer I; Anders HJ; Lech M; Wüthrich RP; Ruddle NH; Moeller MJ; Kozakowski N; Regele H; Browning JL; Heikenwalder M; Segerer S
    Kidney Int; 2016 Jan; 89(1):113-26. PubMed ID: 26398497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta.
    Koni PA; Flavell RA
    J Exp Med; 1998 Jun; 187(12):1977-83. PubMed ID: 9625757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
    Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
    Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.